Skip to main content
logo
Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea flag South Korea · Delayed Price · Currency is KRW
80,900
-1,100 (-1.34%)
At close: Jan 16, 2026

Revenue by Product

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Endoscopic Hemostatic Agent
8.26B
Log In
Log In
Log In
Endoscopic Hemostatic Agent Growth
93.38%
Log In
Log In
Log In
Vascular Embolic Microspheres
788.73M
Log In
Log In
Log In
Vascular Embolic Microspheres Growth
34.02%
Log In
Log In
Log In
Vascular Embolic Microspheres -F
489.21M
Log In
Log In
Log In
Vascular Embolic Microspheres -F Growth
3337.65%
Log In
Log In
Log In
Other
8.40M
Log In
Log In
Log In
Other Growth
-15.98%
Log In
Log In
Log In
Gastrointestinal Stents
-
Log In
Log In
Log In
Gastrointestinal Stents Growth
-
Log In
Log In
Log In
Other
8.40M
Log In
Log In
Log In
Other Growth
-15.98%
Log In
Log In
Log In

Revenue by Geography

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Other
68.96M
Log In
Log In
Log In
Europe
4.40B
Log In
Log In
Log In
United States
4.39B
Log In
Log In
Log In
South Korea
676.12M
Log In
Log In
Log In
South Korea Growth
-86.15%
Log In
Log In
Log In
Other
68.96M
Log In
Log In
Log In